Skip to main content
Top
Published in: International Journal of Hematology 2/2017

01-02-2017 | Images in Hematology

Paradoxical thrombosis in idiopathic thrombocytopenic purpura

Authors: Osamu Imataki, Shumpei Uchida, Shigeyuki Yokokura, Makiko Uemura, Norimitsu Kadowaki

Published in: International Journal of Hematology | Issue 2/2017

Login to get access

Excerpt

A 77-year-old male patient was referred to our hospital with frailty, accompanied with muscle weakness and gait disturbance, and bilateral lower leg resting pain. Blood tests showed severe thrombocytopenia without remarkable coagulopathy, and cranial CT revealed multiple focal hemorrhages (Fig. 1a), which suggested a potential cause for the gait disturbance. At the onset of intracranial hemorrhage, the patient’s platelet count was 0.3 × 104/μL. Diagnostic testing for thrombocytopenia was performed by examining bone marrow aspirate. We diagnosed idiopathic thrombocytopenic purpura (ITP) based on the unrepressed proliferation of megakaryocytes in the hyperplastic bone marrow (day 0). His presentation was not consistent with any other possible differential diagnosis. We did not observe any immunological abnormalities in the blood tests, including anti-cardiolipin antibody and lupus anticoagulant (anti-CL–β2GP1 complex). Soon after the diagnosis of ITP, the patient was treated with prednisolone at 1.0 mg/kg/day. His platelet count immediately recovered from 0.2 × 104 to 13.8 × 104/μL 10 days after corticosteroid treatment. Seventeen days after prednisolone treatment for ITP, the pain in the patient’s right leg was exacerbated, and ischemia and cyanosis were observed (day 17). CT angiography revealed arterial sclerosis obliterans in the right leg (Fig. 1b), with a platelet count of 17.0 × 104/μL and rhabdomyolysis, showing creatinine kinase elevation to 6798 U/L (normal range 40–200 U/L). After recovery of the platelet count, he underwent catheter intervention that restored the blood flow (day 83) (Fig. 1c).
Literature
1.
go back to reference Nørgaard M, Cetin K, Maegbaek ML, Kristensen NR, Ghanima W, Bahmanyar S, et al. Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study. Br J Haematol. 2016;174:639–642CrossRefPubMed Nørgaard M, Cetin K, Maegbaek ML, Kristensen NR, Ghanima W, Bahmanyar S, et al. Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study. Br J Haematol. 2016;174:639–642CrossRefPubMed
Metadata
Title
Paradoxical thrombosis in idiopathic thrombocytopenic purpura
Authors
Osamu Imataki
Shumpei Uchida
Shigeyuki Yokokura
Makiko Uemura
Norimitsu Kadowaki
Publication date
01-02-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2117-9

Other articles of this Issue 2/2017

International Journal of Hematology 2/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine